Suppr超能文献

0.002% 曲伏前列素异丙酯对正常眼压性青光眼眼内压和角膜的影响。

Influence of 0.002% Omidenepag Isopropyl on Intraocular Pressure and the Cornea in Normal Tension Glaucoma.

机构信息

Department of Ophthalmology, Chung-Ang University Hospital, Chung-Ang University College of Medicine.

Departement of Ophthalmology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong City, Gyeonggido.

出版信息

J Glaucoma. 2023 Apr 1;32(4):245-251. doi: 10.1097/IJG.0000000000002167. Epub 2022 Dec 21.

Abstract

PRCIS

Although Omidenepag isopropyl drops elicited stable intraocular pressure reductions in NTG patients, transient changes in refraction and corneal endothelial cells, significant increase of central corneal thickness, and corneal erosion should be considered.

PURPOSE

To analyze the efficacy and safety of 0.002% omidenepag Isopropyl (OMDI) eye drops in patients with normal tension glaucoma (NTG).

METHODS

Medical records for 62 eyes treated with OMDI for ≥6 months were analyzed. Intraocular pressure (IOP), refraction, keratometry, central corneal thickness (CCT), endothelial cell count, coefficient of variation of endothelial cell area (CV), corneal erosion, and central retinal thickness were compared at baseline and 1, 3, and 6 months.

RESULTS

IOP significantly decreased from 13.4±3.8 to 11.9±3.0, 11.7±2.9, and 12.2±3.3 mm Hg at each follow-up ( P <0.001). Endothelial cell count did not change, but CV transiently increased from 12.6 to 17.0 at 1 month, CCT increased from 531.5 to 538.4 μm, myopia changed from -1.5 to -1.9 D, and keratometry changed from 44.5 to 44.7 D. CV, myopia, and keratometry recovered to baseline at 6 months; however, CCT remained high. Significant corneal erosion was observed at 6 months. Central retinal thickness changes were not observed. There were improvements in prostaglandin-associated skin pigmentation (86.7%), eyelash elongation (40.0%), and deepening of the upper eyelid sulcus and ptosis (~30%) at 3 months after exchange to OMDI. Adverse reactions were corneal erosion (27.4%), corneal thickening (21.0%), conjunctival hyperemia (11.3%), photophobia (5.7%), blurred vision (5.7%), and anterior chamber cells (4.8%).

CONCLUSIONS

OMDI eye drops elicited significant and stable IOP reductions after 6 months in NTG patients with low IOP. However, transient myopic and corneal endothelial cell changes, development of corneal thickening, and corneal erosion should be considered when using OMDI.

摘要

PRCIS

尽管 Omidenepag 异丙基滴剂可使正常眼压性青光眼(NTG)患者的眼内压稳定降低,但折射和角膜内皮细胞会发生短暂变化,中央角膜厚度显著增加,角膜侵蚀也应加以考虑。

目的

分析 0.002%Omidenepag 异丙基(OMDI)滴眼液治疗正常眼压性青光眼(NTG)患者的疗效和安全性。

方法

分析了 62 例接受 OMDI 治疗≥6 个月的患者的病历。比较基线及治疗后 1、3、6 个月时的眼压(IOP)、屈光度、角膜曲率、中央角膜厚度(CCT)、内皮细胞计数、内皮细胞面积变异系数(CV)、角膜侵蚀和中心视网膜厚度。

结果

IOP 从基线的 13.4±3.8mmHg 分别显著降低至治疗后 1、3、6 个月的 11.9±3.0mmHg、11.7±2.9mmHg 和 12.2±3.3mmHg(P<0.001)。内皮细胞计数无变化,但 CV 从基线的 12.6%增加至治疗后 1 个月的 17.0%,CCT 从 531.5μm 增加至 538.4μm,近视从-1.5D 变为-1.9D,角膜曲率从 44.5D 变为 44.7D。6 个月时,CV、近视和角膜曲率恢复至基线水平,但 CCT 仍偏高。6 个月时观察到明显的角膜侵蚀。中央视网膜厚度无变化。与基线相比,使用 OMDI 3 个月后,患者的前列腺素相关皮肤色素沉着(86.7%)、睫毛变长(40.0%)、上眼睑凹陷和上睑下垂加深(~30%)均有改善。不良反应有角膜侵蚀(27.4%)、角膜增厚(21.0%)、结膜充血(11.3%)、畏光(5.7%)、视力模糊(5.7%)和前房细胞(4.8%)。

结论

6 个月后,OMDI 滴眼剂可使低眼压性 NTG 患者的眼压显著且稳定降低。然而,使用 OMDI 时应考虑到短暂的近视和角膜内皮细胞变化、角膜增厚和角膜侵蚀的发生。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验